Tianeptine (Tia); 7- [(3-chloro-6,11]-dihydro-6-methyldibenzo [c,f][1,2]thiazepin-11-yl)amino]heptanoic acid S,Sdioxide ( Fig. 1) 1) is an antidepressant agent with a novel neurochemical profile. It increases serotonin (5-hydroxytryptamine; 5-HT) uptake in the brain (in contrast to most antidepressant agents) and reduces stress-induced atrophy of neuronal dendrites. Like the selective serotonin reuptake inhibitors (SSRIs) and in contrast with most tricyclic antidepressant agents, tianeptine does not appear to be associated with adverse cognitive, psychomotor, sleep, cardiovascular or bodyweight effects and has a low propensity for abuse.
Tianeptine (Tia); 7-[(3-chloro-6,11]-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid S,Sdioxide ( Fig. 1) 1) is an antidepressant agent with a novel neurochemical profile. It increases serotonin (5-hydroxytryptamine; 5-HT) uptake in the brain (in contrast to most antidepressant agents) and reduces stress-induced atrophy of neuronal dendrites. Like the selective serotonin reuptake inhibitors (SSRIs) and in contrast with most tricyclic antidepressant agents, tianeptine does not appear to be associated with adverse cognitive, psychomotor, sleep, cardiovascular or bodyweight effects and has a low propensity for abuse. 2) Various methods have been reported in the literature for the analysis of Tia including spectrofluorimetry 3, 4) and voltametry. 5) Reverse-phase high performance liquid chromatography/ fluorescence detection, 6) UV detection 7, 8) and gas chromatography 9) are also reported for determination of Tia from human biological fluids.
According to the literature research, [3] [4] [5] [6] [7] [8] [9] Tia has been ionpair associated with bromophenol blue (BPB), bromocresol green (BCG), bromothymol blue (BTB), methyl orange (MO) and determined by a spectrophotometric method for the first time. The proposed method for tianeptine determination has many advantages over other analytical methods due to its rapidity, lower cost and environmental safety. Unlike the gas chromatographic and HPLC procedures, the instrument is simple and is not costly. All statistical values (percentage recoveries, RSD, confidence limits of the slope and intercept, LOD and LOQ) were within the acceptable limits. Economically, all the analytical reagents are inexpensive and available in any analytical laboratory. The proposed method reports a new for the determination of Tia in pharmaceuticals.
The present paper thus describes fast, simple, sensitive and validated spectrophotometric method for the determination of Tia.
Experimental
Materials Tia and 12.5 mg tablets (Stablon ® ) were gifts from Servier (Istanbul, Turkey). BPB, BCG, BTB, and MO were purchased from Merck (Darmstadt, Germany). All chemicals and solvents used were of analytical and pharmaceutical grades. Water was always distilled.
Solutions A stock solution of 1.0 mg ml Ϫ1 was prepared by dissolving 100 mg of Tia in 100 ml of water. Working standard solutions of Tia of 100 mg ml Ϫ1 were prepared by appropriate dilution of the stock solution with water and were stored 4°C. A 0.02% (w/v) of BPB, BCG, BTB and MO solutions was prepared by dissolving the accurately weighed amount of 20 mg in 100 ml of distilled water.
Phthalate buffer was prepared by dissolving 2.042 g of potassium hydrogen phthalate in 50 ml of water. The pH was adjusted to 3.0 with 0.2 M HCl solution and the volume was made up to 200 ml with water.
Apparatus A Shimadzu UV-160A UV-VIS spectrophotometer with 1 cm quartz cells was used. UV-Visible spectra were automatically obtained by Shimadzu UV-160A system software.
Methods. General Procedure Into a series of 15 ml glass tubes 1 ml buffer solution of pH 3.0 and 1 ml of BPB (BCG, BTB or MO) was added to 1 ml of Tia (100 mg ml
Ϫ1
) solution and mixed well. After 3 min vortexing the tubes were allowed to separate the two layers. The Tia-BPB, Tia-BCG, Tia-BTB and Tia-MO complexes were extracted three times with 3 ml of chloroform. After the phases had been separated by centrifugation, the combined extracts were adjusted to 10 ml with the same solvent. Then the blank experiment was made in which only buffer, reagent and chloroform without Tia solution was used. The absorbance of the organic phase was measured at 411, 414, 415 and 424 nm for Tia-BPB, Tia-BCG, Tia-BTB and Tia-MO complexes, respectively.
Assay Procedure for Tablets Twenty tablets were weighed and ground into a fine powder. An amount of powder equivalent to 100 mg of Tia was weighed into a 100 ml volumetric flask, 30 ml water was then added and shaken thoroughly for about 15 min. The volume was diluted to the mark with water, mixed well and filtered. An aliquot of 10 ml of this solution was transferred to a 100 ml volumetric flask and water added to make up the volume to produce a final concentration of 100 mg ml Ϫ1 . Thereafter, the general procedure was followed.
Stoichiometric Relationship Job's method of continuous variation 10) of equimolar solutions was employed: a 2.0ϫ10
Ϫ5 M standard solution of drug base and 2.0ϫ10 Ϫ5 M solution of BPB, BCG, BTB and MO, respectively, were used.
Method Validation The analytical method was validated according the International Conference for Harmonization (ICH) guidelines 11, 12) under the optimized experimental conditions: linearity, accuracy, precision, specificity and stability of ion pair complex.
Linearity The linearity was evaluated by linear regression analysis, which was calculated by the least squares regression method.
The Limit of Detection (LOD) and Quantification (LOQ) The limit of detection was calculated by LODϭ3.3s/S, where s is the standard deviation of the response of the blank or the standard deviation of intercepts of regression lines and S is the slope of the calibration curve. The limit of quantification was calculated by LOQϭ10s/S under the ICH guidelines. 11, 12) Precision and Accuracy In order to assess the intra-and inter-day precision and accuracy of the assay, ion pair complexes were prepared as described above. The inter-day precision and accuracy were determined by analyzing the three level samples on 3 different days. Precision was expressed as the relative standard deviation (RSD %). Accuracy was expressed as the mean relative error (RME %).
Recovery The recovery method was performed by adding known amounts of the studied compounds to a known concentration of the commercial pharmaceutical tablets (standard addition method).
Specificity A study of some potential interfering substances in the spectrophotometric determination of Tia was performed by selecting them as the excipients (lactose, glucose, saccarose, magnesium stearate) often used in table formulations.
Results and Discussion
Absorption Spectra The absorption spectra of the reaction product between Tia (containing amino group) and BPB, BCG, BTB and MO reagents in acidic medium is shown in Fig. 2 . The absorption spectra of the ion-pairs extracted in chloroform show a maximum at 411, 414, 415 and 424 nm for Tia-BPB, Tia-BCG, Tia-BTB and Tia-MO complexes, respectively.
Effect of pH The effect of pH on the drug-reagent complex was investigated over the pH range 2.5-4.5 using different types of buffer solutions (acetate, borate, phosphate and phthalate). Phthalate buffer (pHϭ3) solution is the best for complex formation to obtain the highest absorbance value in addition to the stability of the colour without affecting the absorbance (Fig. 3) .
Effect of Solvents The solvents studied were water, methanol, ethanol, acetonitrile, acetone, chloroform and dichloromethane. Solvents like n-butanol and benzene cannot be used for extraction of the ion-pairs formed, while 1,2-dichloroethane, methylene chloride and chloroform can extract those ion pairs quantitatively. Experimental results indicated that chloroform gave the maximum and stable absorbance for studied drugs.
Effect of Reagent Concentration When the general procedure was followed with varied amounts of 0.02% (w/v) reagent concentration, maximum and constant absorbance was obtained with 1.0 ml for Tia-complex with BTB, BCG, BPB and MO.
Effect of Reaction Time and Temperature
The optimum reaction time was investigated by following the colour development at ambient temperature (25Ϯ2°C). Complete colour intensity was attained after 3 min of mixing for all complexes.
Stoichiometric Relationship The molar ratio of the drug to reagent in the complex formed was investigated by Job's method of continuous variations which was found to be 1 : 1 (Fig. 4) . 4.0-14.0 and 2.0-10.0 mg ml Ϫ1 for BPB, BCG, BTB and MO methods, respectively; this is good to that reported in another paper. 5) For the BPB method, the regression equation was Aϭ0.066Cϩ1.27ϫ10 Ϫ3 with rϭ0.9999. The limit of quantification (LOQ) was found to be 3.0 mg ml
Ϫ1
. The limit of detection (LOD) was 1.8 mg ml
. For the BCG method, the regression equation was Aϭ0.053Cϩ0.029 with rϭ0.9989. The LOQ was found to be 4.0 mg ml
. The LOD was 2.0 mg ml
. For the BTB method, the regression equation was Aϭ0.052Cϩ0.016 with rϭ0.9999. The LOQ was found to be 4.0 mg ml
. For the MO method, the regression equation was Aϭ0.029Cϩ2.87ϫ10 Ϫ3 with rϭ0.9999. The LOQ was 2.0 mg ml Ϫ1 . The LOD was 1.0 mg ml Ϫ1 (Table 1) . Accuracy and precision was determined from Tia samples at three different concentrations in the calibration range in six replicates. The relative standard deviation (RSD) on the absorbance from three replicate solutions was found to be between 0.22 and 0.72%. The data is summarized in Table 2 .
The recoveries of the standard addition method (Table 3 ) suggested that high accuracy of the proposed methods. Recoveries were found to be between % 98.67 and 100.23, better than those reported in other paper. 5) A stability study of the colored ion-pair complex was developed and showed that yellow color was stable for 8 h at room temperature.
A study of some potential interfering substances in the spectrophotometric determination of Tia was performed by selecting some excipients often used in table formulations. There was no interference from most of the common ingredients such as lactose, glucose, saccarose, and magnesium stearate It was shown that these compounds do not interfere with the proposed method.
Analysis of Pharmaceutical Formulations
The developed method was applied for the determination of Tia in tablets. The results were compared statistically with those obtained by the official method 13) using t-and F-tests. There was no significant difference between the two methods in the respect of mean values and standard deviations at 95 % con- fidence level.
Conclusion
The proposed method for Tia determination has many advantages over other analytical methods due to its rapidity, lower cost, instrumental simplicity, environmental safety and better sensitivity.
The method can be successfully employed for Tia quantification in all types of pharmaceutical preparations and liquid samples, such as urine, serum, plasma. 6) 
